E. Suazo-Zepeda

National and state-level colorectal cancer mortality trends in Mexico, 1998-2018.

K. Van Loon, M. Lajous, F. Huitzil-Meléndez, 2021, Salud publica de Mexico.

Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis

T. Hiltermann, G. Sidorenkov, P. Vinke, 2021, Cancer Immunology, Immunotherapy.

Quality of life after treatment with immune checkpoint inhibitors for lung cancer; the impact of age.

M. Heuvelmans, G. Sidorenkov, P. Vinke, 2022, Lung cancer.

Reduction in the Treatment Gap for Breast Cancer in Mexico under Seguro Popular, 2007 to 2016

M. Reich, A. Mohar, M. Lajous, 2022, Health systems and reform.

Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study

M. Kersten, D. Maucort-Boulch, M. Jalali, 2023, BMJ Open.